Rankings
▼
Calendar
IRWD Q3 2017 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
IRWD
Ironwood Pharmaceuticals, Inc.
$603M
Q3 2017 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$87M
+31.3% YoY
Gross Profit
$81M
93.0% margin
Operating Income
-$19M
-22.4% margin
Net Income
-$32M
-37.2% margin
EPS (Diluted)
$-0.22
QoQ Revenue Growth
+33.4%
Cash Flow
Operating Cash Flow
-$31M
Free Cash Flow
-$33M
Stock-Based Comp.
$9M
Balance Sheet
Total Assets
$625M
Total Liabilities
$643M
Stockholders' Equity
-$18M
Cash & Equivalents
$163M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$87M
$66M
+31.3%
Gross Profit
$81M
$29M
+182.5%
Operating Income
-$19M
-$28M
+31.3%
Net Income
-$32M
-$33M
+2.7%
← FY 2017
All Quarters
Q4 2017 →